47 min listen
Developments and Scandals Related to Genetic Testing and Technology in Neurology (Delayed Recall May 2019)
Developments and Scandals Related to Genetic Testing and Technology in Neurology (Delayed Recall May 2019)
ratings:
Length:
60 minutes
Released:
May 16, 2019
Format:
Podcast episode
Description
This month’s Delayed Recall highlights episodes on developments and scandals related to genetic testing and technology in neurology. Dr. Jason Crowell and Dr. Josephine Johnston of the Hastings Center start the show discussing the ethical and philosophical implications of gene editing., which first aired on December 18th, 2018. The next segment, also from December 18th, has Dr. Stacey Clardy and Dr. Stefan Pulst focusing on the scientific and societal impact of the recent first reported gene editing using the CRISPR technology. Following this segment is one from December 3rd and finds Dr. Jeff Waugh talking with Dr. Saadet Andrews about her paper on the genetic landscape of pediatric movement disorders and management implications. This episode continues with an interview on a Neurology: Genetics on the long journey to diagnosis for patients with mitochondrial disease between Dr. Jason Crowell and Drs. John L.P. Thompson and Michio Hirano from April 3rd, 2018. The episode wraps up with a talk between Dr. Jeffrey Ratliff and Dr. Thomas Bird from March 20th, 2018, on Dr. Bird’s Neurology: Clinical Practice paper on the benefits and limitations of exome sequencing to identify hereditary ataxias.
Released:
May 16, 2019
Format:
Podcast episode
Titles in the series (100)
November 6 2007 Issue: Nonsteroidal anti-inflammatory drugs may protect against Parkinson disease by Neurology® Podcast